Tyra Biosciences Alternatives & Competitors
12 companies similar to Tyra Biosciences — TYRA is focused on developing next-generation precision medicines that target la...
Companies similar to Tyra Biosciences
Flare Therapeutics
Trailblazing the path to drugging transcription factors to discover precision medicines fo...
Cambridge, United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Boston, United States
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
South San Francisco, Unit...
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
Rival Readout
Competing with Tyra Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Kinnate Biopharma Inc.
Inspiring Hope to Those Battling Cancer
San Diego, United States
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
PineTree Therapeutics Inc
Disruptive Innovations to Treat Unmet Therapeutic Needs in Oncology
Cambridge, United States
Tavros Therapeutics
Leading the new frontier of targeted cancer therapies exploiting tumors’ genetic vulnerabi...
Durham, United States
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Cambridge, United States
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Nexo Therapeutics
We’re driven to translate the most compelling and still undrugged targets in human biolog...
Watertown, United States
AtG Therapeutics
Overcoming Tumor Adaptation - inhibiting escape mechanisms both in treatment naive and res...
Spain
About Tyra Biosciences
Tyra Biosciences, founded in 2018, is a clinical-stage biotechnology firm headquartered in the United States. The company is developing next-generation precision medicines focusing on large opportunities in FGFR biology. Through its proprietary platform, SNÅP, Tyra Biosciences rapidly refines structural drug design usi...
Development of precision molecules, Clinical research and studies, Oral drug development
Patients with non-muscle invasive bladder cancer (NMIBC), Patients with upper tract urothelial carcinoma (UTUC), Patients with achondroplasia, Healthcare professionals, Parents or caregivers of children with achondroplasia, Advocacy groups related to achondroplasia
Precision Medicine, FGFR Biology, Oncology, Clinical-stage Biotechnology, SNÅP Platform, Drug Resistance, Fibroblast Growth Factor Receptor (FGFR), Small Molecule Drug Discovery, Bladder Cancer, Genetically Defined Conditions, Targeted Oncology, Structural Drug Design, Selective Inhibitors, Drug Discovery Engine, Tumor Resistance
B2B
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tyra Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tyra Biosciences on 3 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
